Company Filing History:
1 out of 3,221 
1 out of 39 
Years Active: 2021
Title: Florian Gnad: Innovator in Cancer Diagnosis and Treatment
Introduction
Florian Gnad is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer research. His innovative work focuses on methods for diagnosing and treating cancer, particularly through the analysis of specific genetic markers.
Latest Patents
Florian Gnad holds a patent titled "Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes." This invention provides methods for identifying subjects with cancer, such as lung cancer, by analyzing the expression levels of NRF2 splice variants or target genes. Additionally, it outlines treatment methods using NRF2 pathway antagonists for subjects expressing these genetic markers. He has 1 patent to his name.
Career Highlights
Throughout his career, Florian Gnad has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Foundation Medicine, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer diagnostics and therapeutics.
Collaborations
Florian has collaborated with esteemed colleagues in his field, including Christiaan Nicolaas Klijn and James M Lee. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Florian Gnad's work in cancer diagnosis and treatment exemplifies the impact of innovative thinking in the medical field. His contributions continue to pave the way for advancements in cancer care and research.